The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Chengcheng Fu | EBMT 19 | CAR T-cell therapy in the front-line treatment of patients with high-risk multiple myeloma

Mar 28, 2019

45th Annual Meeting of the EBMT, 24–27 March 2019, Frankfurt, DE

Chengcheng Fu

The First Affiliated Hospital of Soochow University, Suzhou, CH

Chengcheng Fu | EBMT 19 | CAR T-cell therapy in the front-line treatment of patients with high-risk multiple myeloma